July 30, 2022 10:00 am ET Listen to article (2 minutes) CVS Health Starbucks and Uber Technologies are among the companies headlining another busy earnings week as investors look for signs of a recess...
Tag: PFE
Pfizer Raises Covid-19 Vaccine Price 27%. What It Means for the Stock.
Text size Pfizer said it has signed a deal to supply the U.S. with vaccines in the fall, while Moderna has yet to announce a sale. Jacob King – WPA Pool / Getty Images Pfizer has raised the U.S....
Novartis Will Cut 8,000 Jobs Under CEO’s Shake-Up Plan
Text size Vasant Narasimhan, CEO of Novartis. ERIC PIERMONT/AFP/Getty Images Pharmaceutical giant Novartis said Tuesday it will lay off more than 7% of its workforce, just a few months after CEO Vas N...
Roivant, Pfizer unveil Priovant Therapeutics focused on autoimmune disease treatments, Roivant stock surges
Shares of Roivant Sciences Ltd. ROIV, -2.30% shot up 10.0% in premarket trading Tuesday, after the biopharmaceutical company and drug giant Pfizer Inc. PFE, +0.56% unveiled Priovant Therapeutics, a bi...
U.S. Stocks Poised to Open Lower on Monday Ahead of Fed Week
Stocks are poised to open lower on Monday. (Photo by Spencer Platt/Getty Images) Getty Images Text size U.S. stocks were poised for a lower opening on Monday ahead of the Federal Reserve’s decision on...
Novavax’s New Covid-19 Vaccine Might Be Late to the Party
It’s one thing to arrive fashionably late to a party, it’s another thing to waltz in when the last guests are stumbling out the door. For Novavax , which on Tuesday cleared a key step toward U.S. Food...
Turning Point Stock Doubles on Bristol Deal. What It Means for Biotech M&A.
Text size Photograph by Georges Gobet/AFP/Getty Images Turning Point Therapeutics stock has more than doubled after Bristol Myers Squibb announced that it had agreed to buy the company. It’s just the ...
Stocks Are Ready for a Bounce Higher After S&P 500 Closes Above Bear Market
Text size Dreamstime The stock market came awfully close to finishing Friday in a bear market, at least 20% off its peak in early January. Many investors would like to see it get there so Wall Street ...
BioNTech Earnings Top Forecasts on Strong Sales of Covid-19 Vaccine
Text size BioNTech is continuing to work with Pfizer on follow-on Covid-19 vaccines. (Photo by THOMAS LOHNES/AFP via Getty Images) BioNTech , the German biotech company, reported first-quarter earning...
Big Pharma Has Enough Cash to Buy All of Biotech. Why M&A Isn’t Happening.
Text size Late last year, Barron’s predicted a wave of deals, citing biotech companies’ cash holdings. Above, the plates used to print one-dollar bills. Alex Wong/Getty Images With biotech...
As Pfizer Faces a Period of Volatility, Here’s My Plan for the Shares
The numbers for Pfizer (PFE) are excellent. The guidance? Meh. Pfizer released the firm’s first quarter financial performance on Tuesday morning. Pfizer posted adjusted EPS of $1.62 (GAAP EPS of...
Pfizer revenue growth soars 77% as PFE beats earnings estimates by almost $1 billion
On May 3, Pfizer (NYSE: PFE) posted a blowout quarter, with revenue growth of 77% year-on-year (YoY) and earnings per share (EPS) growth of 70.53%. Further, the company reaffirmed its full-year 2022 f...
Covid Pfizer (PFE) earnings Q1 2022
Albert Bourla, chief executive officer of Pfizer pharmaceutical company, arrives to ring the closing bell at the New York Stock Exchange. Drew Angerer | Getty Images Pfizer on Tuesday slashed its 2022...
Pfizer’s New CFO David Denton Negotiated One of the Biggest Healthcare Deals in History
Pfizer on Monday named a new chief financial officer with a resume that hints at the company’s plans to spend big with its Covid-19 vaccine windfall. David Denton is taking up the CFO role at Pfizer (...
Pfizer, Moderna and J&J Face Shareholder Pressure to Broaden Covid-19 Vaccine Access
Socially conscious investors and global-health activists are turning to shareholders to press Covid-19 vaccine manufacturers Pfizer Inc., Moderna Inc. and Johnson & Johnson to make more of their s...
Pfizer’s new ulcerative colitis drug improves clinical remission rates in Phase 3 study
Shares of Pfizer Inc. PFE, +0.71% gained 0.2% in premarket trading on Wednesday after the company said the experimental ulcerative colitis drug it bought through the recent Arena Pharmaceuticals deal ...
S&P 500 marks 1st death cross in 2 years as investors assess Russia-Ukraine ahead of Fed decision
Dow industrials barely gained on Monday, while the S&P 500 logged its first death cross in two years and the Nasdaq Composite slumped to its lowest since December 2020, as investors monitored Russ...
‘The capitulation model for biotech is a Category 5 storm, the same as energy in 2020’ — why contrarians say the sector is a buy
If you want to know how much investors hate the biotech sector right now, consider this simple statistic: More than 25% of small biotech companies have stock-market capitalizations that are smaller th...